For research use only. Not for therapeutic Use.
Oclacitinib Maleate(CAT: C000297) is a pharmaceutical compound that acts as a novel Janus kinase (JAK) inhibitor. Its action method involves inhibiting specific enzymes, known as JAKs, which play a key role in signaling pathways related to inflammation and immune responses. Oclacitinib Maleate is primarily used in veterinary medicine to treat inflammatory conditions in dogs, such as allergic dermatitis and atopic dermatitis. Its role in pharmaceuticals is significant, particularly in the development of targeted therapies for inflammatory and immune-mediated diseases.
| Catalog Number | C000297 |
| CAS Number | 1640292-55-2 |
| Molecular Formula | C₁₉H₂₇N₅O₆S |
| Purity | ≥95% |
| Target | Stem Cell/Wnt |
| Solubility | DMSO (Slightly), Methanol (Slightly) |
| Appearance | White to Off-White Solid |
| Storage | -20°C, Inert atmosphere |
| Reference | (1) Gonzales, A.J., et al.: J. Vet. Pharmacol. Ther., 37, 317 (2014)(2) Collard, W. T., et al.: J Vet Pharmacol Ther. 37, 279 (2014) |
